Feifei Li

1.8k total citations
47 papers, 1.1k citations indexed

About

Feifei Li is a scholar working on Molecular Biology, Plant Science and Cancer Research. According to data from OpenAlex, Feifei Li has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 8 papers in Plant Science and 8 papers in Cancer Research. Recurrent topics in Feifei Li's work include Extracellular vesicles in disease (5 papers), Bioactive Natural Diterpenoids Research (4 papers) and Natural product bioactivities and synthesis (4 papers). Feifei Li is often cited by papers focused on Extracellular vesicles in disease (5 papers), Bioactive Natural Diterpenoids Research (4 papers) and Natural product bioactivities and synthesis (4 papers). Feifei Li collaborates with scholars based in China, United States and Czechia. Feifei Li's co-authors include Yan Zhang, Donghui Wen, Tianjiao Dai, Lüjun Chen, Aolin Li, Huimin Xie, Chuan Xu, Xia Zhang, Wen Li and Hui‐Kuan Lin and has published in prestigious journals such as Nucleic Acids Research, Environmental Science & Technology and Advanced Functional Materials.

In The Last Decade

Feifei Li

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Li China 19 545 206 158 152 125 47 1.1k
Qian Zhou China 25 1.0k 1.9× 133 0.6× 332 2.1× 76 0.5× 372 3.0× 77 2.0k
Li Lv China 19 660 1.2× 114 0.6× 145 0.9× 143 0.9× 65 0.5× 52 1.3k
Kamil Brzóska Poland 18 335 0.6× 70 0.3× 126 0.8× 116 0.8× 51 0.4× 43 995
Jing Qiao China 18 319 0.6× 96 0.5× 100 0.6× 68 0.4× 38 0.3× 42 816
Kan Li China 19 369 0.7× 95 0.5× 95 0.6× 82 0.5× 108 0.9× 42 960
Qi Shen China 21 935 1.7× 57 0.3× 203 1.3× 194 1.3× 150 1.2× 69 1.5k
Xinyan Wu China 20 412 0.8× 93 0.5× 128 0.8× 64 0.4× 28 0.2× 53 1.0k
Shailendra Kumar India 20 769 1.4× 61 0.3× 51 0.3× 43 0.3× 185 1.5× 57 1.3k
Yixin Zhao China 18 418 0.8× 208 1.0× 195 1.2× 88 0.6× 153 1.2× 81 1.2k
Wenxuan Li China 17 184 0.3× 213 1.0× 45 0.3× 117 0.8× 40 0.3× 70 906

Countries citing papers authored by Feifei Li

Since Specialization
Citations

This map shows the geographic impact of Feifei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Li more than expected).

Fields of papers citing papers by Feifei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Li. The network helps show where Feifei Li may publish in the future.

Co-authorship network of co-authors of Feifei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Li. A scholar is included among the top collaborators of Feifei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Li. Feifei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Feifei, Yixuan Wang, Shuai Chen, et al.. (2025). Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages. European Heart Journal. 46(45). 4933–4949. 3 indexed citations
2.
Li, Feifei, et al.. (2025). Inhibition of hemangioma development by regulating the VEGF/VEGFR autocrine loop via the miR-494/PTEN pathway. Discover Oncology. 16(1). 168–168. 1 indexed citations
3.
Li, Hongbin, Jialin Zhang, Boyi Yu, et al.. (2024). RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis. Radiotherapy and Oncology. 200. 110528–110528. 4 indexed citations
4.
Wang, Yiran, Yan Huang, Feifei Li, et al.. (2024). Study on the mechanism of herb cake-partitioned moxibustion inhibiting tumor growth in colitis-associated colorectal cancer based on KDM4D receptor. Journal of Acupuncture and Tuina Science. 22(1). 1–11. 2 indexed citations
5.
Wang, Yixuan, Feifei Li, Yu Liu, et al.. (2024). Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging. Journal of Nanobiotechnology. 22(1). 85–85. 2 indexed citations
6.
Deng, Huaxiang, Yulan Qiu, Feifei Li, et al.. (2024). Pathway Evolution Through a Bottlenecking‐Debottlenecking Strategy and Machine Learning‐Aided Flux Balancing. Advanced Science. 11(14). e2306935–e2306935. 12 indexed citations
7.
Yu, Changhao, Fanyuan Yu, Feifei Li, & Ling Ye. (2023). The Establishment of a Murine Mandibular Molar Extraction Socket Healing Model. Journal of Visualized Experiments. 1 indexed citations
9.
Chen, Qixin, Jiaying Li, Feng Han, et al.. (2022). A Multifunctional Composite Hydrogel That Rescues the ROS Microenvironment and Guides the Immune Response for Repair of Osteoporotic Bone Defects. Advanced Functional Materials. 32(27). 127 indexed citations
10.
Wu, Yuanyuan, Feifei Li, Yang Zhang, et al.. (2022). Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: Coupling network pharmacology with experimental validation. Journal of Ethnopharmacology. 293. 115326–115326. 8 indexed citations
11.
Chen, Shuai, Feifei Li, Zhiming Wu, et al.. (2022). High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery. BMC Cardiovascular Disorders. 22(1). 282–282. 3 indexed citations
12.
Shu, Yisong, Feifei Li, Penglong Wang, et al.. (2022). Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents. Frontiers in Chemistry. 10. 969770–969770. 6 indexed citations
13.
Li, Feifei & Sheng Liu. (2022). Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. Frontiers in Immunology. 13. 1083462–1083462. 29 indexed citations
14.
Li, Guoping, Herong Cui, Qi Zhang, et al.. (2022). Systems pharmacology and GC-MS metabolomics reveal the efficacy and mechanisms of zedoary oil on acute liver injury induced by oxidative stress. Phytomedicine. 104. 154295–154295. 1 indexed citations
15.
Dong, Zhiwu, Qiang Guo, Shuang Liang, et al.. (2021). Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer’s Disease. Molecular Neurobiology. 58(7). 3084–3094. 80 indexed citations
16.
Wu, Jie, Ling Guo, Yong Ren, et al.. (2020). Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation. British Journal of Cancer. 123(11). 1673–1685. 44 indexed citations
18.
Zhang, Yan, Aolin Li, Tianjiao Dai, et al.. (2017). Cell-free DNA: A Neglected Source for Antibiotic Resistance Genes Spreading from WWTPs. Environmental Science & Technology. 52(1). 248–257. 226 indexed citations
19.
Zhang, Hui, Feifei Li, Yan Jia, et al.. (2017). Characteristic arrangement of nucleosomes is predictive of chromatin interactions at kilobase resolution. Nucleic Acids Research. 45(22). 12739–12751. 15 indexed citations
20.
Zhang, Jingjing, et al.. (2015). Oxidative effects, nutrients and metabolic changes in aquatic macrophyte, Elodea nuttallii, following exposure to lanthanum. Ecotoxicology and Environmental Safety. 115. 159–165. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026